In November 2026, Aima Diagnostics was invited to join Norway Health Tech, a leading Norwegian health technology cluster bringing together organisations across healthcare, medical technology, research and industry.
Norway Health Tech unites healthcare providers, universities, research institutions, technology companies and investors to accelerate the development and adoption of innovative healthcare solutions.
This invitation gives Aima Diagnostics an opportunity to strengthen its engagement with Norway’s health innovation ecosystem and expand collaboration with clinical, research and industry partners.
Aima Diagnostics develops AI-powered technologies for laboratory test interpretation, biomarker analysis and clinical decision support. Its solutions are designed to help physicians, medical laboratories and healthcare providers derive greater clinical value from laboratory data, supporting more personalised and data-driven healthcare.
Through collaboration with Norway Health Tech, the company aims to explore opportunities for joint research and the responsible integration of AI technologies into laboratory medicine.
The long-term ambition of Aima Diagnostics is to contribute to the development of internationally recognised approaches and standards for AI-assisted laboratory data interpretation, while supporting the responsible adoption of artificial intelligence in modern diagnostics.
By Line Strøm
November 20, 2026